Abstract: The invention relates to the use of substances as a fundamental constituent in wound healing agents. The invention is characterised in that said substances bond to either IAP and/or integrin ?v?3 and/or thrombuspondin-1 in such a way that the bond between thrumbospondin-1 and IAP and/or integrin ?v?3 is inhibited.
Type:
Grant
Filed:
February 21, 2002
Date of Patent:
September 1, 2009
Assignee:
Dermatools Biotech GmbH
Inventors:
Mark Freyberg, Peter Friedl, Dirk Kaiser